Pharmacokinetics of New HCV NS3 Protease Inhibitor...

Antimicrobial Agents and Chemotherapy 2016 / 09

Pharmacokinetics of New HCV NS3 Protease Inhibitor Narlaprevir Following Single Dose Use with or without Ritonavir in patients with liver cirrhosis.

Isakov, V, Koloda, D, Tikhonova, N, Kikalishvili, T, Krasavina, E, Lekishvili, K, Malaya, I, Ryska, M, Samsonov, M, Tolkacheva, V
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.01044-16
Date:
September, 2016
File:
PDF, 823 KB
english, 2016
Conversion to is in progress
Conversion to is failed